… when given as first-line treatment for Asian patients with non-small-cell lung cancer (NSCLC) …
compared with standard chemotherapy for first-line treatment of European patients with …

… This analysis was performed on the safety set (116 VAI patients and 93 BuMel patients),
excluding patients who did not receive the treatment allocated by randomization, similar to the as…

… This study did not support a change in the standard of care for patients with ES with isolated
pulmonary metastases. The overall results were better than anticipated on the basis of …

… -based combination chemotherapy is … chemotherapy needs to be made, the following
factors should be taken into consideration: (a) chemotherapy is appropriate for selected patients …

… ) for those treated with standard chemotherapy (59 deaths in 70 patients) versus 77 weeks
(… treated with intensified chemotherapy (55 deaths in 70 patients) whereas, in patients with ED…

… For patients who had a PR after standard chemotherapy, radiotherapy was mandatory. All
areas with macroscopically residual disease after eight cycles of CHVmP/BV were irradiated (…

… Of note, in a post hoc subgroup analysis, American and European patients seemed to
benefit in terms of overall survival with bevacizumab while Asians did not [39]. These findings …

… chemotherapy regimens. The goals of this study were to assess the incidence and risk of
chemotherapy-… in breast cancer and lymphoma patients undergoing chemotherapy in Europe. …

… 70% of patients receiving highly emetogenic chemotherapy were protected from acute emesis.
However, 40% of patients … )-antagonists to standard therapy significantly improves emesis …

… In a population of patients with high-risk soft-tissue sarcoma, we did … chemotherapy regimen
over the standard chemotherapy regimen. The benefit seen with the standard chemotherapy …